Combo could be new standard for transplant-eligible, newly diagnosed myeloma patientsSeptember 20, 2019Multiple Myeloma
Adding elotuzumab to lenalidomide/dexamethasone can prolong survival in relapsed/refractory myelomaSeptember 19, 2019Multiple Myeloma
CT103A elicits responses after prior CAR T-cell relapseSeptember 19, 2019Multiple MyelomaCellular Therapy
Melflufen-dexamethasone active in patients with relapsed/refractory myeloma and EMDSeptember 19, 2019Multiple Myeloma
Progressive myeloma after induction? Go straight to transplantSeptember 6, 2019Multiple MyelomaTransplant
Cardiovascular complications most common with carfilzomib in relapsed myelomaAugust 9, 2019Multiple MyelomaPatient & Survivor Care
Recombinant vaccine cut herpes zoster rate in immunocompromised patientsJuly 9, 2019Patient & Survivor CareMultiple MyelomaTransplant
